OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AGIG$1.1758

Abundia Global Impact Group, Inc

Diversified ChemicalsVerified

The company's capital structure is characterized by a high level of equity with no long-term debt, as evidenced by a debt-to-equity ratio of 0.0. This indicates a strong equity base, supported by a current ratio of 10.05, which suggests robust short-term liquidity. However, the company's liquidity position is still categorized as low, which may indicate potential challenges in managing short-term obligations despite the high current ratio. Profitability metrics reveal a challenging financial position for the company. The return on equity (ROE) is -0.0089 and the return on assets (ROA) is -0.0086, both indicating a negative return on investment. These figures are significantly below the industry norms for diversified chemicals, suggesting that the company is underperforming in terms of generating returns for its shareholders and utilizing its assets efficiently. The company's revenue is concentrated in a single business segment, as there are no disclosed segments in the financial data. Geographically, the data does not provide specific details on revenue concentration by region, but the company's operations are likely to be influenced by the global chemicals market. The growth trajectory of the company is uncertain, as the financial data does not provide specific outlook figures for the current or next fiscal year. The company reported a net loss of $89,090, and the negative operating income of $410,250 indicates a decline in operational performance. This suggests that the company may face challenges in achieving revenue growth in the near term. Risk factors for the company include the potential for dilution, although the risk is currently categorized as low. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is not a significant concern at this time. The company's financial performance and the absence of long-term debt suggest that it is not currently under pressure to issue additional shares to raise capital. Recent events related to the company include the publication of its latest financial data, which shows a significant net loss and negative operating income. There are no specific recent filings or transcripts mentioned in the data that would indicate significant changes in the company's operations or strategic direction.

30-day price · AGIG-0.13 (-10.6%)
Low$1.01High$1.31Close$1.10As of16 May, 00:00 UTC
Profile
CompanyAbundia Global Impact Group, Inc
TickerAGIG.K
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Abundia Global Impact Group, Inc is a diversified chemicals company that operates within the basic materials sector, primarily engaged in the production and distribution of chemical products.

Classification. The company is classified under the industry of Diversified Chemicals within the Basic Materials economic sector, with a classification confidence of 0.92.

The company's capital structure is characterized by a high level of equity with no long-term debt, as evidenced by a debt-to-equity ratio of 0.0. This indicates a strong equity base, supported by a current ratio of 10.05, which suggests robust short-term liquidity. However, the company's liquidity position is still categorized as low, which may indicate potential challenges in managing short-term obligations despite the high current ratio. Profitability metrics reveal a challenging financial position for the company. The return on equity (ROE) is -0.0089 and the return on assets (ROA) is -0.0086, both indicating a negative return on investment. These figures are significantly below the industry norms for diversified chemicals, suggesting that the company is underperforming in terms of generating returns for its shareholders and utilizing its assets efficiently. The company's revenue is concentrated in a single business segment, as there are no disclosed segments in the financial data. Geographically, the data does not provide specific details on revenue concentration by region, but the company's operations are likely to be influenced by the global chemicals market. The growth trajectory of the company is uncertain, as the financial data does not provide specific outlook figures for the current or next fiscal year. The company reported a net loss of $89,090, and the negative operating income of $410,250 indicates a decline in operational performance. This suggests that the company may face challenges in achieving revenue growth in the near term. Risk factors for the company include the potential for dilution, although the risk is currently categorized as low. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is not a significant concern at this time. The company's financial performance and the absence of long-term debt suggest that it is not currently under pressure to issue additional shares to raise capital. Recent events related to the company include the publication of its latest financial data, which shows a significant net loss and negative operating income. There are no specific recent filings or transcripts mentioned in the data that would indicate significant changes in the company's operations or strategic direction.
Key takeaways
  • The company has a strong equity base with no long-term debt, as indicated by a debt-to-equity ratio of 0.0.
  • The company is underperforming in terms of profitability, with a negative return on equity and return on assets.
  • The company's financial data does not provide specific details on revenue concentration by segment or region.
  • The company's growth trajectory is uncertain, with a reported net loss and negative operating income.
  • The risk of dilution is currently low, and there are no immediate filing-based liquidity or dilution flags.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's margin outlook is negative due to the reported negative gross profit and operating income.
  • **rd_outlook_rationale**: There is no specific information provided on the company's research and development outlook.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$115.8k
Gross profit-$26.4k
Operating income-$410.2k
Net income-$89.1k
R&D
SG&A
D&A
SBC
Operating cash flow$87.8k
CapEx
Free cash flow-$61.0k
Total assets$10.4M
Total liabilities$443.3k
Total equity$10.0M
Cash & equivalents
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.3M-$1.0M-$1.0M-$893.1k
FY-3$1.6M-$777.9k-$744.3k-$553.9k
FY-2$794.0k-$4.6M-$3.2M-$3.0M
FY-1$0.00-$8.0M-$3.6M-$3.9M
FY0$410.6k-$29.6M-$29.5M-$39.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$10.7M$10.3M
FY-3$11.7M$11.3M
FY-2$10.4M$10.0M
FY-1$4.1M-$2.1M$525.8k
FY0$31.9M$19.0M$4.6M
PeriodOCFCapExFCFSBC
FY-4-$680.7k-$42.8k-$893.1k
FY-3-$229.0k-$15.1k-$553.9k
FY-2$263.2k$0.00-$3.0M
FY-1-$1.9M-$318.5k-$3.9M
FY0-$8.1M-$10.0M-$39.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$115.8k-$410.2k-$89.1k-$61.0k
FQ-6$0.00-$544.7k-$264.6k-$256.9k
FQ-5$0.00-$4.7M-$1.7M-$1.7M
FQ-4$102.3k-$1.1M-$1.0M-$1.0M
FQ-3$110.6k-$1.8M-$1.8M-$1.8M
FQ-2$225.7k-$20.2M-$20.4M-$20.4M
FQ-1$184.9k-$6.7M-$6.9M-$8.0M
FQ0$133.0k-$5.1M-$5.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$10.4M$10.0M
FQ-6$10.2M$9.8M
FQ-5$4.1M-$2.1M$525.8k
FQ-4$7.2M$7.0M
FQ-3$8.7M$8.4M
FQ-2$28.8M$16.3M
FQ-1$31.9M$19.0M$4.6M
FQ0$35.3M$16.2M
PeriodOCFCapExFCFSBC
FQ-7$87.8k-$61.0k
FQ-6-$1.4M-$347.1k-$256.9k
FQ-5-$1.9M-$318.5k-$1.7M
FQ-4-$1.3M-$1.0M
FQ-3-$2.8M-$1.8M
FQ-2-$4.6M-$8.8M-$20.4M
FQ-1-$8.1M-$10.0M-$8.0M
FQ0-$3.8M-$1.8M
Valuation
Market price$1.17
Market cap$51.2M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B5.1
P/Tangible book5.1
Tangible book$10.0M
Net cash
Current ratio10.1
Debt/Equity0.0
ROA-0.9%
ROE-0.9%
Cash conversion-99.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
MetricAGIGActivity
Op margin-354.2%6.3% medp25 2.1% · p75 9.6%bottom quartile
Net margin-76.9%3.3% medp25 0.2% · p75 6.4%bottom quartile
Gross margin-22.8%23.5% medp25 13.2% · p75 31.9%bottom quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-5.5% medp25 -11.2% · p75 -3.8%
Debt / equity0.0%42.1% medp25 16.7% · p75 82.4%bottom quartile
Observations
IR observations
Mean price target6.00 USD
Median price target6.00 USD
High price target6.00 USD
Low price target6.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.14 USD
Last actual EPS-0.90 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 16:36 UTC#b64dcb09
Market quoteclose USD 1.09 · shares 0.04B diluted
no public URL
2026-05-16 16:36 UTC#5c9806eb
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:04 UTCJob: 7a7070d6